gavin
Topics Engaged In
-
- Topic
- Voices
- Posts
- Last Post
-
-
[Pharmacological characteristics and clinical study results of Pemigatinib (Pema
Started by:
in: Chemotherapy & More
- 1
- 1
- 2 years, 8 months ago
-
Infigratinib Shows Promising Early Activity in FGFR2-Altered Cholangiocarcinoma
Started by:
in: Chemotherapy & More
- 1
- 1
- 2 years, 8 months ago
-
Imfinzi plus chemotherapy significantly improved overall survival in 1st-line ad
Started by:
in: Chemotherapy & More
- 1
- 1
- 2 years, 8 months ago
-
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliar
Started by:
in: Chemotherapy & More
- 1
- 1
- 2 years, 8 months ago
-
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and le
Started by:
in: Chemotherapy & More
- 1
- 1
- 2 years, 8 months ago
-
Cholangiocarcinoma: new perspectives for new horizons
Started by:
in: New Developments
- 1
- 1
- 2 years, 8 months ago
-
Laparoscopic liver resection with open partial resection of the thoracoabdominal
Started by:
in: Surgery, Resection & Transplant Treatment Options
- 1
- 1
- 2 years, 9 months ago
-
Potential influence of the microbiome environment in patients with biliary tract
Started by:
in: New Developments
- 1
- 1
- 2 years, 9 months ago
-
Effect of vascular resection for perihilar cholangiocarcinoma: a systematic revi
Started by:
in: Surgery, Resection & Transplant Treatment Options
- 1
- 1
- 2 years, 9 months ago
-
Current options and future directions of systemic therapy for advanced biliary t
Started by:
in: New Developments
- 1
- 1
- 2 years, 9 months ago
-
[A new classification of intrahepatic cholangiocarcinoma based on actual anatomy
Started by:
in: New Developments
- 1
- 1
- 2 years, 9 months ago
-
Current and emerging therapies for advanced biliary tract cancers
Started by:
in: New Developments
- 1
- 1
- 2 years, 9 months ago
-
Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcin
Started by:
in: Radiation Treatments & Options
- 1
- 1
- 2 years, 9 months ago
-
[Pharmacological characteristics and clinical study results of Pemigatinib (Pema